» Articles » PMID: 35842731

Notch-activated Mesenchymal Stromal/stem Cells Enhance the Protective Effect Against Acetaminophen-induced Acute Liver Injury by Activating AMPK/SIRT1 Pathway

Overview
Publisher Biomed Central
Date 2022 Jul 16
PMID 35842731
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Notch signaling plays important roles in regulating innate immunity. However, little is known about the role of Notch in mesenchymal stromal/stem cell (MSC)-mediated immunomodulation during liver inflammatory response.

Methods: Notch activation in human umbilical cord-derived MSCs was performed by a tissue culture plate coated with Notch ligand, recombinant human Jagged1 (JAG1). Mice were given intravenous injection of Notch-activated MSCs after acetaminophen (APAP)-induced acute liver injury. Liver tissues were collected and analyzed by histology and immunohistochemistry.

Results: MSC administration reduced APAP-induced hepatocellular damage, as manifested by decreased serum ALT levels, intrahepatic macrophage/neutrophil infiltration, hepatocellular apoptosis and proinflammatory mediators. The anti-inflammatory activity and therapeutic effects of MSCs were greatly enhanced by Notch activation via its ligand JAG1. However, Notch2 disruption in MSCs markedly diminished the protective effect of MSCs against APAP-induced acute liver injury, even in the presence of JAG1 pretreatment. Strikingly, Notch-activated MSCs promoted AMP-activated protein kinase (AMPKα) phosphorylation, increased the sirtuins 1 (SIRT1) deacetylase expression, but downregulated spliced X-box-binding protein 1 (XBP1s) expression and consequently reduced NLR family pyrin domain-containing 3 (NLRP3) inflammasome activation. Furthermore, SIRT1 disruption or XBP1s overexpression in macrophages exacerbated APAP-triggered liver inflammation and augmented NLRP3/caspase-1 activity in MSC-administrated mice. Mechanistic studies further demonstrated that JAG1-pretreated MSCs activated Notch2/COX2/PGE2 signaling, which in turn induced macrophage AMPK/SIRT1 activation, leading to XBP1s deacetylation and inhibition of NLRP3 activity.

Conclusions: Activation of Notch2 is required for the ability of MSCs to reduce the severity of APAP-induced liver damage in mice. Our findings underscore a novel molecular insights into MSCs-mediated immunomodulation by activating Notch2/COX2/AMPK/SIRT1 pathway and thus provide a new strategy for the treatment of liver inflammatory diseases.

Citing Articles

[MiR-139-5p regulates the Notch/RBP-J/Hes1 axis to promote homing of bone mesenchymal stem cells in bronchial asthma].

Wang K, Fang H, Cao X, Zhu Z Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(12):2283-2290.

PMID: 39725616 PMC: 11683343. DOI: 10.12122/j.issn.1673-4254.2024.12.03.


Mesenchymal stromal cells alleviate APAP-induced liver injury via extracellular vesicle-mediated regulation of the miR-186-5p/CXCL1 axis.

Zhao E, Liang R, Li P, Lu D, Chen S, Tan W Stem Cell Res Ther. 2024; 15(1):392.

PMID: 39490995 PMC: 11533353. DOI: 10.1186/s13287-024-03995-8.


Metabolic mechanisms orchestrated by Sirtuin family to modulate inflammatory responses.

Li X, Li Y, Hao Q, Jin J, Wang Y Front Immunol. 2024; 15:1448535.

PMID: 39372420 PMC: 11449768. DOI: 10.3389/fimmu.2024.1448535.


Roles of X-box binding protein 1 in liver pathogenesis.

Tak J, Kim Y, Kim S Clin Mol Hepatol. 2024; 31(1):1-31.

PMID: 39355873 PMC: 11791611. DOI: 10.3350/cmh.2024.0441.


Mesenchymal stem cells-derived exosomes alleviate liver fibrosis by targeting Hedgehog/SMO signaling.

Zong R, Zheng Y, Yan Y, Sun W, Kong L, Huang Y Hepatol Int. 2024; 18(6):1781-1791.

PMID: 39138757 DOI: 10.1007/s12072-024-10717-y.


References
1.
Martinon F, Chen X, Lee A, Glimcher L . TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol. 2010; 11(5):411-8. PMC: 3113706. DOI: 10.1038/ni.1857. View

2.
Larson A, Polson J, Fontana R, Davern T, Lalani E, Hynan L . Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005; 42(6):1364-72. DOI: 10.1002/hep.20948. View

3.
Zhu Q, Wang H, Jiang B, Ni X, Jiang L, Li C . Loss of ATF3 exacerbates liver damage through the activation of mTOR/p70S6K/ HIF-1α signaling pathway in liver inflammatory injury. Cell Death Dis. 2018; 9(9):910. PMC: 6125320. DOI: 10.1038/s41419-018-0894-1. View

4.
Kopan R, Ilagan M . The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009; 137(2):216-33. PMC: 2827930. DOI: 10.1016/j.cell.2009.03.045. View

5.
Owen A, Newsome P . Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?. Am J Physiol Gastrointest Liver Physiol. 2015; 309(10):G791-800. PMC: 4652139. DOI: 10.1152/ajpgi.00036.2015. View